Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...
Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...
The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions of successors to Ozempic and Wegovy.
Doctor's Best Inc., a leading nutritional supplement company, has been named a recipient of the 2026 Women's Choice Award(R) for its High Absorption Magnesium. The award recognizes brands based on ...
People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...
Draper recently received an up to $26.7 million other transaction award (OTA) from the Advanced Research Projects Agency for Health (ARPA-H). The award supports the agency's Computational ADME-Tox and ...
An informational 2026 consumer report examining Purisaki Berberine Patches' transdermal delivery claims, ingredient research ...
A research team from Tianjin Normal University has developed a new approach to the precise chemical synthesis of carbon nanotubes, which could pave the way for their on-demand customization. Known for ...
Exciting new human and animal studies designed to enhance business opportunities KELOWNA, BC / ACCESS Newswire / March 4, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a ...
A new review titled Artificial Intelligence and the Discovery of Antibiotics: Reinventing with Opportunities, Challenges, and ...
Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company specializing in oral thin film ...
Advances in machine learning and shape-memory polymers are enabling engineers to design for mechanical performance first and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results